In short
Overview
There is no membership at this clinic, and the reason is worth explaining rather than leaving as a gap on the price list.
Direct Answer
Memberships price care by frequency. But there is no evidence base for an optimal check up frequency, and general health checks did not reduce mortality across 14 randomised trials covering over 180,000 people.
So a subscription charges you for an interval that has not been shown to help, and creates a reason to keep testing.
Instead, consultations and tests are quoted individually, and the review interval is set by your age and risk.
Who This Applies To
- A consultation quoted before it happens
- Each test quoted before it is ordered, with a stated reason
- A review interval set for you: about every three years under 50 without chronic conditions, yearly from 50
- Cardiovascular risk every three to five years if low, yearly at borderline or above
- Continuity with the same doctor, which is the part that is measurably worth having
Option Comparison / Decision Criteria
What memberships usually bundle, and whether it helps
| An annual check for everyone | Under 50 without chronic conditions, about every three years is the reasonable interval |
| More tests at higher tiers | Usually whole body imaging, multi cancer panels or biological age scores. None shown to improve outcomes |
| Unlimited consultations | Genuinely useful for some people, and the one component that can be worth paying for |
| Priority access | Legitimate, and about convenience rather than medicine |
The structural problem
A subscription creates an incentive to demonstrate value through activity, and in preventive medicine activity usually means testing. Since testing has harms as well as costs, that incentive points the wrong way.
False positives lead to further tests and procedures. Overdiagnosis means treating disease that would never have caused harm, and that treatment arrives within weeks while any benefit takes years.
What the yield actually does over time
The first check finds everything accumulated over years. Later ones find only what is new, so fewer cases and a higher proportion of false positives among the positives. That is an argument for longer intervals, not shorter ones.
Why an In-Person Physician Review Matters
What is worth paying for repeatedly Continuity.
Patients with an established relationship with one clinician have higher rates of appropriate preventive care, lower incidence and mortality from colorectal and breast cancer, and lower overall mortality. That comes from seeing the same doctor, not from seeing one more often. Why the trend beats the snapshot A blood pressure of 134 means something different rising from 118 than falling from 152. Reading your numbers against last time is genuinely valuable, and it works at three year intervals as well as at one. What happens between appointments Anything new is dealt with when it happens rather than saved for a scheduled slot. A new symptom, a side effect, an abnormal result from elsewhere, or a new diagnosis in a close relative should all be brought forward. That does not require a membership. It requires knowing who to contact.
Cost & Timeline
How to evaluate a membership you have been offered
- What is the recommended interval for someone your age, and what is the evidence for it?
- Which tests are included, and what would each change if abnormal?
- Does a higher tier buy more consultation time or more tests?
- Is it the same doctor each time?
- What happens if you need something outside the plan?
If the answer to question three is more tests, the higher tier is likely to be worse value in outcome terms as well as in money.
What happens here
Each appointment and test quoted before it happens. An interval set by your age and risk rather than sold. A monitoring schedule agreed at the start where you are on treatment that needs it, with its annual cost stated.
An annual review can be booked as a single appointment even if you are seen elsewhere otherwise.
Frequently Asked Questions
Because memberships price care by frequency, and there is no evidence base for an optimal check up frequency. General health checks did not reduce mortality across 14 randomised trials and over 180,000 people.
About every three years under 50 without chronic conditions, yearly from 50, and cardiovascular risk every three to five years if low. Anyone with a chronic condition is reviewed regularly regardless of age.
Then there is a defined schedule, agreed at the start, with its annual cost stated. That applies to testosterone, hormone therapy, GLP-1 medication and blood pressure or lipid treatment.
Not necessarily. Unlimited consultation time and priority access are legitimate things to pay for. The question is whether the higher tiers buy more time or simply more tests.